Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Travis Reeder"'
Autor:
Scott A. Tomlins, Nickolay A. Khazanov, Benjamin J. Bulen, Daniel H. Hovelson, Melissa J. Shreve, Laura E. Lamb, Marc R. Matrana, Mark E. Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield, E. Claire Dees, Adedayo A. Onitilo, Michael Thompson, Gary L. Buchschacher, Alan M. Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon C. Hwang, J. Marie Suga, Robert Siegel, William Irvin, Suresh Nair, Jennifer N. Slim, Jamal Misleh, Jamil Khatri, Gregory Masters, Sachdev Thomas, Malek Safa, Daniel M. Anderson, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Komal Plouffe, Eric Czuprenski, Jennifer Hipp, Travis Reeder, Hana Vakil, D. Bryan Johnson, Daniel R. Rhodes
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-14 (2023)
Tomlins et al. develop an Immunotherapy Response Score (IRS) to predict clinical benefit from checkpoint inhibition across solid tumors. IRS integrates TMB and gene expression, is evaluable from FFPE material, and is predictive for real-world progres
Externí odkaz:
https://doaj.org/article/4592ab4c5780454fabd8956daa3f8f79
Autor:
Nickolay Khazanov, Melissa Shreve, Laura Lamb, Daniel Hovelson, Marc Matrana, Mark Burkard, Eddy Yang, William Edenfield, Claire Dees, Adedayo Onitilo, Michael Thompson, Gary Buchschacher, Alan Miller, Alexander Menter, Benjamin Parsons, Timothy Wassenaar, Leon Hwang, J. Suga, Robert Siegel, William Irvin, Suresh Nair, Jennifer Slim, Kat Kwiatkowski, Khalis Mitchell, Tina Hu-Seliger, Stephanie Drewery, Andrew Fischer, Jennifer Hipp, Travis Reeder, Hana Vakil, Bryan Johnson, Daniel Rhodes, Scott Tomlins
Pembrolizumab is approved in many advanced solid tumor types, however predictive biomarkers and the proportion of pembrolizumab-benefiting patients vary. Biomarkers beyond PD-L1 immunohistochemistry, microsatellite instability (MSI) status, and tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d44f832c2a2425bf32a36e8fa251391
https://doi.org/10.21203/rs.3.rs-1225960/v1
https://doi.org/10.21203/rs.3.rs-1225960/v1
Autor:
Daniel R. Rhodes, D. Bryan Johnson, Travis Reeder, Kat Kwiatkowski, Daniel H. Hovelson, Jennifer Hipp, Jayson Falkner, Hana Vakil, Lorena Lazo de la Vega, Stephanie Drewery, Khalis Mitchell, Javed Siddiqui, Paul W. Harms, Andrew H. Fischer, Scott A. Tomlins
Publikováno v:
The Journal of molecular diagnostics : JMD. 23(11)
Despite widespread use in targeted tumor testing, multiplex PCR/semiconductor (Ion Torrent) sequencing-based assessment of all comprehensive genomic profiling (CGP) variant classes has been limited. Herein, we describe the development and validation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::162ca6186939abb309a6a62a2989e5f5
https://pubmed.ncbi.nlm.nih.gov/34454112
https://pubmed.ncbi.nlm.nih.gov/34454112
Autor:
Eddy S. Yang, Malek M. Safa, Daniel R. Rhodes, Hana Vakil, Kat Kwiatkowski, Travis Reeder, Daniel H. Hovelson, Scott A. Tomlins, William Jeffery Edenfield, Mark E. Burkard, Bryan Johnson, Khalis Mitchell
Publikováno v:
Journal of Clinical Oncology. 39:2609-2609
2609 Background: P is approved in many ST types, however predictive biomarkers and the proportion of pts who benefit vary widely. Biomarkers beyond PD-L1 immunohistochemistry and comprehensive genomic profiling (CGP) based tumor mutation burden (TMB)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b23fa70179deaad9c5b3360dd490ca5
https://doi.org/10.1200/jco.2021.39.15_suppl.2609
https://doi.org/10.1200/jco.2021.39.15_suppl.2609
Autor:
Kat Kwiatkowski, Marc R. Matrana, Elizabeth Claire Dees, Jamil Khatri, Daniel M. Anderson, Daniel R. Rhodes, Jennifer Nadine Slim, Jennifer Marie Suga, Jayson Falkner, Eddy S. Yang, Hana Vakil, Alex R. Menter, Mark E. Burkard, Bryan Johnson, Malek M. Safa, Daniel H. Hovelson, Travis Reeder, Scott A. Tomlins, Han A. Koh, Benjamin M. Parsons
Publikováno v:
Journal of Clinical Oncology. 38:3574-3574
3574 Background: Tissue-based h-CGP is increasingly utilized for treatment selection in patients with advanced solid tumors but has high tumor surface area [TSA] requirements (≥25mm2 for leading commercial tests). P-CGP is recommended when tissue i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb68a0d30abf8eb0c5e595297f576d14
https://doi.org/10.1200/jco.2020.38.15_suppl.3574
https://doi.org/10.1200/jco.2020.38.15_suppl.3574
Publikováno v:
MOJ Proteomics & Bioinformatics. 5
Non-invasive prenatal genetic testing (NIPT) is an advance in the detection of fetal chromosomal aneuploidies that analyzes cell-free DNA (cfDNA) in the blood of a pregnant woman. NIPT has quickly spread across the globe after introduction into clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec74b3c5f756c5ff74713a9ca98b259f
https://doi.org/10.15406/mojpb.2017.05.00147
https://doi.org/10.15406/mojpb.2017.05.00147